A prominent example of reduced glutamine synthesis is Alzheimer's disease, in which both decreased expression and hampered activity of GS are commonly observed (Olabarria et al. 2011; Jones et al. 2017; Fan et al. 2018, 2021). This evidence concerns the gene GLUL and Alzheimer disease.